PATRICIA MARVIN: Open Payments
NPI 1093897878 · CRESCENT CITY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$211 in 11 payments from 7 companies in 2025. Trend: 2023 $379 · 2024 $410 · 2025 $211
Food & beverage: $211
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $58 |
| ABBVIE INC. | 2 | $54 |
| GlaxoSmithKline, LLC. | 2 | $29 |
| Novo Nordisk Inc | 1 | $23 |
| Lilly USA, LLC | 1 | $18 |
| Verona Pharma, Inc. | 1 | $15 |
| Exact Sciences Corporation | 1 | $14 |
Products named: CAPLYTA, VRAYLAR, TRELEGY ELLIPTA, Ozempic, ZEPBOUND, Ohtuvayre, Cologuard Collection Kit.
Industry payments across FL — which companies pay providers there.
